Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts

Neuroscience

Volumn 75, Issue 4, 1996, Pages 979-985

  Rosenblad, C ^a   Martinez Serrano, A ^a   Bjorklund A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

6 hydroxydopamine; amphetamine induced rotation; dopamine neuron; glial cell line derived neurotrophic factor; transplantation

Indexed keywords

AMPHETAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; INTRACEREBRAL DRUG ADMINISTRATION; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030298512     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00343-0     Document Type: Letter

References (29)

1. 1. Abercrombie M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec. 94, 239-247.
2. 2. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A. and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
3. 3. Beck K. D., Irwin I., Valverde J., Brennan T. J., Langsten J. W. and Hefti F. (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16, 665-673.
4. 4. Björklund A., Stenevi U., Schmidt R. H., Dunnett S. B. and Gage F. H. (1983) Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta physiol. scand. 522 Suppl., 1-7.
5. 5. Brundin P. and Björklund A. (1987) Survival, growth and function of dopaminergic neurons grafted to the brain. In Progress in Brain Research (eds Seil F. J., Herbert E. and Carlson B. M.), Vol. 71, pp. 293-308. Elsevier, Amsterdam.
6. 6. Choi-Lundberg D. L. and Bohn M. C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Devl Brain Res. 85, 80-88.
7. 7. Engele J. and Bohn M. C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11, 3070-3078.
8. 8. Gundersen H. J. G., Bendtsen T. F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sorensen F. B., Vesterby A. and West M. J. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta pathol. microbiol. immun. scand. 96, 379-394.
9. 9. Hudson J., Granholm A.-C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P., Leela N. S., Mackerlova L., Lile J. D., Collins F. and Hoffer B. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425-432.
10. 10. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopuolos G. D., Squinto S. P. and Lindsay R. M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
11. 11. Johansson M., Friedmann M., Hoffer B. and Strömberg I. (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Expl Neurol. 134, 25-34.
12. 12. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
13. 13. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S. and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
14. 14. Lin L.-F. H., Zhang T. J., Collins F. and Armes L. G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63, 758-768.
15. 15. Lindvall O. (1984) Neural transplantation in Parkinson's desease. In Functional Neural Transplantation (eds Dunnett S. B. and Björklund A.), pp. 103-137. Raven, New York.
16. 16. Magal E., Burnham P., Varon S. and Louis J.-C. (1993) Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra. Neuroscience 52, 867-881.
17. 17. Nakao N., Frodl E. M., Widner H., Carlson E., Eggerding F. A., Epstein C. J. and Brundin P. (1995) Overexpressing Cu/Zn Superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's desease. Nature Med. 1, 226-231.
18. 18. Nikkah G., Odin P., Smits A., Tingström A., Othberg A., Brundin P., Funa K. and Lindvall O. (1993) Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Expl Brain Res. 92, 516-523.
19. 19. Olanow C. W., Kordower J. H. and Freeman T. B. (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109.
20. 20. Poulsen K. T., Armanini M. P., Klein R. D., Hynes M. A., Phillips H. S. and Rosenthal A. (1994) TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
21. 21. Sauer H., Rosenblad C. and Björklund A. (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. natn. Acad. Sci. U. S. A. 92, 8935-8939.
22. 22. Sauer H. and Oertel W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde and immunocytochemical study in the rat. Neuroscience 59, 401-415.
23. 23. Sauer H. and Brundin P. (1991) Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2, 123-135.
24. 24. Schaar D. G., Sieber B.-A., Dreyfus C. F. and Black I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Expl Neurol. 124, 368-371.
25. 25. Springer J. E., Mu X., Bergmann L. W. and Trojanowski J. Q. (1994) Expression of GDNF mRNA in rat and human nervous tissue. Expl Neurol. 127, 167-170.
26. 26. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B. and Humpel C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Expl Neurol. 124, 401-412.
27. 27. Tomac A., Lindqvist E., Lin L.-F. H., Ogren S. O., Young D., Hoffer B. J. and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
28. 28. Tomac A., Widefalk J., Lin L.-F. H., Kohno T., Ebendal T., Hoffer B. and Olson L. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. natn. Acad. Sci. U. S. A. 92, 8274-8278.
29. 29. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-93.